1. A Multi Center, Epidemiological Study of Bone Tuberculosis in Southwest China from 2011 to 2023
- Author
-
Xiaopeng Qin, Boli Qin, Chenxing Zhou, Chong Liu, Tianyou Chen, Jichong Zhu, Chengqian Huang, Shaofeng Wu, Rongqing He, Songze Wu, Sitan Feng, Jiarui Chen, Jiang Xue, Wendi Wei, Liyi Chen, Kechang He, Zhendong Qin, Tiejun Zhou, Jie Ma, and Xinli Zhan
- Subjects
Epidemiological characteristics ,Bone-TB ,Drug resistance ,Disease burden ,Cost assessment ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background Despite continued efforts to manage and control Tuberculosis (TB) in China, it remains a major health concern. Bone tuberculosis (Bone-TB), a common form of extrapulmonary tuberculosis, still adds considerably to the global TB case load. Diagnosing Bone-TB is often difficult as its symptoms can be similar to other bone or joint diseases, which leads to delayed detection and treatment. Currently, comprehensive reports on the epidemiological aspects of Bone-TB in China are scarce. Methods This retrospective study analyzed demographic and clinical data from 2,191 patients diagnosed with Bone-TB in Southwest China between January 2011 and September 2023.This study fully reveals the characteristics of Bone-TB in Southwest China. Results The overall trend of bone tuberculosis was a slow rise. Among 2191 patients, males, farmers, aged 42–68 years, and people with HIV and diabetes are the priority groups for the prevention and treatment of Bone-TB. The majority of the infected spines (1556/2191) were located in the thoracic vertebra (759/2191) and lumbar vertebra (715/2191). Forty-nine (2.24%) patients had drug-resistant TB (DR-TB). Forty-five (2.05%) died during the treatment. The total and actual hospitalization. Costs amounted to $3,837.10 and $1,914.35 (p
- Published
- 2024
- Full Text
- View/download PDF